The risk of malignancy index (RMI) in women with adnexal masses in Wales
Tài liệu tham khảo
Ferlay, 2010
Public Health Wales NHS Trust, 2010
2011
Jacobs, 1990, A risk of malignancy index incorporating CA 125, ultrasound and menopausal status for the accurate preoperative diagnosis of ovarian cancer, Br J Obstet Gynaecol, 97, 922, 10.1111/j.1471-0528.1990.tb02448.x
Tingulstad, 1996, Evaluation of a risk of malignancy index based on serum CA125, ultrasound findings and menopausal status in the pre-operative diagnosis of pelvic masses, Br J Obstet Gynaecol, 103, 826, 10.1111/j.1471-0528.1996.tb09882.x
Tingulstad, 1999, The risk-of-malignancy index to evaluate potential ovarian cancers in local hospitals, Br J Obstet Gynaecol, 93, 448, 10.1097/00006250-199903000-00028
Guideline Development Group, 2011
van den Akker, 2010, Evaluation of the Risk of Malignancy Index in daily clinical management of adnexal masses, Gynecol Oncol, 116, 384, 10.1016/j.ygyno.2009.11.014
Akdeniz, 2009, Risk of malignancy index for adnexal masses, Eur J Gynaecol Oncol, 30, 178
Obeidat, 2004, Risk of malignancy index in the preoperative evaluation of pelvic masses, Int J Gynaecol Obstet, 85, 255, 10.1016/j.ijgo.2003.10.009
Ma, 2003, A risk of malignancy index in preoperative diagnosis of ovarian cancer, Chin Med J (Engl), 116, 396
Terzić, 2011, Evaluation of the risk malignancy index diagnostic value in patients with adnexal masses, Vojnosanit Pregl, 68, 589, 10.2298/VSP1107589T
Enakpene, 2009, Preoperative evaluation and triage of women with suspicious adnexal masses using risk of malignancy index, J Obstet Gynaecol Res, 35, 131, 10.1111/j.1447-0756.2008.00869.x
Davies, 1993, The adnexal mass: benign or malignant? Evaluation of a risk of malignancy index, Br J Obstet Gynaecol, 100, 927, 10.1111/j.1471-0528.1993.tb15109.x
Harry, 2009, The risk of malignancy index for ovarian tumours in Northeast Scotland–a population based study, Scott Med J, 54, 21, 10.1258/rsmsmj.54.2.21
Zweig, 1993, Receiver-operating characteristic (ROC) plots: a fundamental evaluation tool in clinical medicine, Clin Chem, 39, 561, 10.1093/clinchem/39.4.561
Manjunath, 2001, Comparison of three risk of malignancy indices in evaluation of pelvic masses, Gynecol Oncol, 81, 225, 10.1006/gyno.2001.6122
Kader Ali Mohan, 2010, Risk Malignancy Index (RMI) in patients with abnormal pelvic mass: comparing RMI 1, 2 and 3 in an Australian population, Aust N Z J Obstet Gynaecol, 50, 77, 10.1111/j.1479-828X.2009.01105.x
Moolthiya, 2009, The risk of malignancy index (RMI) in diagnosis of ovarian malignancy, Asian Pac J Cancer Prev, 10, 865
Morgante, 1999, Comparison of two malignancy risk indices based on serum CA125, ultrasound score and menopausal status in the diagnosis of ovarian masses, Br J Obstet Gynaecol, 106, 524, 10.1111/j.1471-0528.1999.tb08318.x
Aslam, 2000, Prospective evaluation of three different models for the pre-operative diagnosis of ovarian, BJOG, 107, 1347, 10.1111/j.1471-0528.2000.tb11646.x
Yazbek, 2006, A comparative study of the risk of malignancy index and the ovarian crescent sign for the diagnosis of invasive ovarian cancer, Ultrasound Obstet Gynecol, 28, 320, 10.1002/uog.2842
Public Health Observatory for Wales, 2009
